Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Nivalis Therapeutics, Inc.
With
Primary Objective: * Assess the efficacy of N91115 at 12 weeks when added to preexisting treatment with lumacaftor/ivacaftor in adult patients with CF who are homozygous for the F508del-CFTR mutation Secondary Objectives: * Assess the effect of N91115 added to lumacaftor/ivacaftor on safety * Assess the effect of lumacaftor/ivacaftor added to N91115 on the pharmacokinetics of N91115, lumacaftor, and ivacaftor
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted